None
Conditions
Interventions
Control group A:Postoperative routine treatment
Test group B:Postoperative conventional treatment supplemented with Danggui Buxue Decoction therapy
Sponsors
Chengdu Hospital of Integrated Traditional Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 20-70 years, both males and females are eligible; (2) Diagnosed with hepatocellular carcinoma, hepatic hemangioma, or hepatic abscess undergoing right or left hemi-hepatectomy; (3) General conditions such as cardiopulmonary and renal function are good; (4) No metastatic tumors outside the liver; (5) Complete resection of the surgical lesion; (6) TCM constitutional differentiation diagnosis indicates deficiency of Qi and Blood in patients.
Exclusion criteria
Exclusion criteria: (1) Significant dysfunction of vital organs; (2) Patients with concomitant liver cirrhosis; (3) Patients undergoing palliative treatment due to incomplete resection; (4) Postoperative pathological diagnosis not consistent with liver cancer; (5) Severe allergy to Danggui Buxue Decoction: allergic shock, bleeding, difficulty breathing, etc.; (6) Patients unable to complete the course of treatment due to various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alanine Aminotransferase;Aspartate Aminotransferase;Alkaline Phosphatase;Gamma-Glutamyltransferase;Total Protein;total bilirubin;white blood cell;Hemoglobin;liver volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| Concurrent disorders; | — |
Countries
China
Contacts
Public ContactWen Xudong
Chengdu Hospital of Integrated Traditional Chinese and Western Medicine
Outcome results
None listed